Johnson & Johnson products on a shelf in a store in New York. Luca Jackson | Reuters Johnson & Johnson’s Consumer health company Kenvue valued its IPO Wednesday at $22 per share, at the high end of its quoted range, in a boosted deal that would raise about $3.8 billion. At this IPO price, the …
Continue reading “Costs, what you need to learn about Shopper Well being Spinoff”
